LLY Eli Lilly and Company
NYSE · Health Care · Pharmaceutical Preparations · Market cap $1.02T · $1,142.85 on 2026-10-02
Above StickerTier ADetailed (TTM)
Price moves
1 week-3%
1 month-1%
3 months-6%
6 months22%
YTD7%
1 year36%
Off 52w high-12%
52w range$784–$1,293
Price and total return
PriceTotal return (dividends reinvested)
Show year-end values
| Year | Price | Dividend-adjusted |
|---|---|---|
| 2016 | $73.55 | $63.31 |
| 2017 | $84.46 | $74.60 |
| 2018 | $115.72 | $104.77 |
| 2019 | $131.43 | $121.68 |
| 2020 | $168.84 | $159.46 |
| 2021 | $276.22 | $264.82 |
| 2022 | $365.84 | $355.54 |
| 2023 | $582.92 | $572.09 |
| 2024 | $772.00 | $762.60 |
| 2025 | $1,074.70 | $1,069.50 |
| 2026-10-02 (latest) | $1,142.80 | $1,142.80 |
Dividend-adjusted values are back-adjusted to today's price: the gap to the price column is the value of dividends reinvested since then.
Ten Cap
$314
$314
Buy (MOS)
$447
$447
Payback Time
$495
$495
Sticker
$894
$894
Price
$1,143
$1,143
Valuation
| Buy (MOS) 50% of Sticker | $446.85 | -61% |
|---|---|---|
| Ten Cap 10× owner earnings | $313.85 | -73% |
| Payback Time 8-year FCF payback | $495.43 | -57% |
| Sticker Rule #1 intrinsic value | $893.70 | -22% |
| Windage growth g | 15.0% | |
| Future P/E (min 2g, 10y median) | 30.0× | |
| P/E · 10y median | 38.4× | 40.1× |
| EPS TTM 2026-06-30 | $29.79 | |
| FCF yield | 2.8% | |
| Dividend (TTM) · yield | $6.69 | 0.6% |
| Dividend growth 5y, per year | 15.3% | |
| Total return per year, dividends reinvested · 5y · 10y | 38.2% | 35.1% |
| Revenue · net income last FY | $65.2B | $20.6B |
Big Five 14/15 tests ≥10%
| 10y | 5y | 1y | |
|---|---|---|---|
| ROIC | 23% | 24% | 31% |
| Sales growth | 13% | 22% | 45% |
| EPS growth | 26% | 28% | 96% |
| BVPS growth | 8% | 37% | 87% |
| OCF growth | 19% | 21% | 91% |
| Debt payoff (yrs of FCF) | 2.4 |
Events
8-K: 2026-08-05: 2.02 Earnings release; next report ~2026-11-04
Next report ≈ 2026-11-04 · SEC filings ·Yahoo Finance